Incidence, Outcomes, and Risk Factors of Pleural Effusion in Patients Receiving Dasatinib Therapy for Philadelphia Chromosome-Positive Leukemia

Haematologica - Italy
doi 10.3324/haematol.2018.188987
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Effective Re-Induction Therapy With Dasatinib and Clofarabine in Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Drugs and Therapy Studies
2012English

Severe Thrombocytopenia After Dasatinib Treatment in a Patient With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

OncoTargets and Therapy
OncologyPharmacology
2015English

Natural Killer or Natural Killer/T Cell Lineage Large Granular Lymphocytosis Associated With Dasatinib Therapy for Philadelphia Chromosome Positive Leukemia

Haematologica
Hematology
2009English

Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

Pharmacokinetics of Dasatinib for Philadelphia-Positive Acute Lymphocytic Leukemia With Acquired T315I Mutation

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2012English

Philadelphia Chromosome and Leukemia

Annals of Internal Medicine
Internal MedicineMedicine
1970English

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Expressing P190BCR-Abl.

Internal Medicine
Internal MedicineMedicine
2002English

Incidence and Aetiology of Eosinophilic Pleural Effusion

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2009English

The Positive Outcomes for Patients Receiving Animal Assisted Therapy After Lung Transplantation

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy